BioNTech signs deal to co-develop OncoC4's cancer drug

BioNTech signs deal to co-develop OncoC4's cancer drug

Submitted by admin on March 21, 2023 - 10:05am
Source: 
Reuters
News Tags: 
BioNTech
OncoC4
cancer
oncology
drug development
ONC-392
Headline: 
BioNTech signs deal to co-develop OncoC4's cancer drug
snippet: 

Germany's BioNTech SE (22UAy.DE) said on Monday that it signed a deal with privately held OncoC4 Inc to co-develop and commercialize its cancer antibody drug candidate.

Do Not Allow Advertisers to Use My Personal information